axial3D, a Belfast, UK- and Claymont, Del.-based medical 3D printing company, closed a USD$3m funding round.
The round was led by Imprimatur Capital Fund Management, with participation from Techstart Ventures, Clarendon Fund Managers and Innovation Ulster.
The company intends to use the funds to expand its machine learning team, which builds automated algorithms, grow into the USA opening an office in the region.
Led by Daniel Crawford, CEO, axial3D is a medical 3D printing company specializing in the use of patient-specific medical models to advance both standards and efficiency of surgical intervention. Creating precise 3D models generated from patient CT, MRI and PET data, the technology enhances pre-operative planning by personalizing healthcare.